Search Results
Dr Tolaney on Data With Checkpoint Inhibitor Combinations in Metastatic TNBC
Dr. Sara Tolaney on Eribulin Plus Pembrolizumab for Metastatic Triple-Negative Breast Cancer
Sara M. Tolaney, MD, MPH, on the efficacy & safety of combination eribulin + pembrolizumab
Metastatic HER2 Negative Breast Cancer: Emerging Novel Treatment Strategies
Evolving treatment paradigms in metastatic breast cancer
Optimal chemotherapy combinations in TNBC gBRCA subtypes
Case 3: The Use of Combination Therapy in Triple-Negative Breast Cancer
Metastatic Triple-Negative Breast Cancer Ongoing Trials
Tesetaxel Plus Checkpoint Inhibitors Among Patients With Metastatic Triple-Negative Breast Cancer
Checkpoint inhibitors for triple-negative breast cancer
PD-1 therapy with eribulin for triple negative MBC
Breast Cancer and the Immune System at MBC Patient Forum 2019
